Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By white_Tiger (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

An Under-the-Radar Growth Story with Strong Fundamentals…In An Unloved Industry

% of readers think this story is Fact. Add your two cents.


If you are a premium member make sure you sign in to see All the exclusive content In This Issue.

We have one under-the-radar stock in our Run to $1 Model Portfolio which stands to benefit significantly from President Trump’s policies aimed at reviving U.S. fossil fuel energy production and bolstering economic expansion.

Under previous administrations, many smaller companies within the fossil fuel energy sector were dismissed as obsolete. The lack of valuation expansion in some traditional energy stocks has been driven by unfavorable political sentiment, a lack of pro-growth initiatives, and investor neglect.

However, we believe the new U.S. administration’s efforts to ease operational constraints and stimulate U.S. oil and gas production will rejuvenate the traditional energy industry.

This shift should lead to increased revenues, lower costs, improved profitability, and increased valuation for certain stocks that we follow in the industry.

About Our Run to One Dollar (R21) Model Portfolio

Historically, the R21 Model Portfolio has identified some of the best-performing stocks in our coverage, with a ~45% average return across 49 stocks during the portfolio’s 11-year tenure. It includes multiple R21 stocks with current returns in the 100s of percent, like Tss, Inc. (NASDAQ:TSSI) (7105%), ZYXI (2077%), Pharmchem, Inc. (OOTC:PCHM) (690%), and Paysign, Inc. (NASDAQ:PAYS) (443%). While we still need to do more research and channel checks on our new addition, some of the characteristics that led us to this new R21 mirror those of our past winners. As a reminder, the portfolio is composed of stocks trading under $1 that we believe have the potential to eventually surpass the one-dollar mark, with a likelihood to become multibaggers. (Note: All returns noted are as of 2/4/2025)

he recent pullback in this stock in focus appears to be driven more by investor ignorance than by any fundamental weakness.

It’s rare to see a company’s stock price decline at the precise moment when geopolitical and macroeconomic factors align to fuel its growth.

But that’s exactly what happens in the misunderstood microcap universe, where the absence of institutional investors creates opportunities for those who recognize mispriced value before the broader market takes notice.

Reasons to be bullish:

  • Price to earnings (P/E) ratio of only 5.6x
  • Consistently Profitable – This company has delivered nine consecutive quarters of positive earnings, showing steady financial performance.
  • Impressive Margins – Net margins sit at a range of 10% to 17%, with additional tax loss carryforwards expected to keep profits strong for years to come.
  • Sustained Revenue Growth – The company has maintained steady growth, reporting a 15% increase in fiscal 2024 revenue over the prior year. The first quarter of fiscal 2025 continued this momentum with a over 30% year-over-year revenue increase, driven by new customer additions and favorable market conditions.
  • Lean and Efficient Operations – Running with just a handful of employees and minimal overhead, the company maximizes cash flow while maintaining service quality.
  • Limited Competition – The primary competitor is a multi-billion-dollar company, yet this business has carved out a niche by offering faster service and better customer relationships.
  • Expansion Potential Without Dilution – Management has no plans to raise dilutive capital or take on debt, instead focusing on self-funded growth.
  • Tapping Into Underpenetrated Markets – Demand remains high, and the company is expanding its footprint into new regions and customer segments.
  • Proven Resilience in Market Cycles – Even in downturns, the company benefits from customer reinvestment in critical infrastructure, ensuring steady demand.
  • Insider Commitment – The CEO has personally financed operations and previously executed a multi-million share buyback, signaling confidence in the company’s future.
  • Growth Bottleneck is Inventory, Not Demand – The company is turning away business simply due to limited inventory, meaning that as it reinvests profits, revenues could accelerate further.

Please also note that we were able to get the CEO on for a live fireside chat conversation with our analyst team, and with our community present, which was his first ever investor-facing appearance. The conversation is archived on our Pro-Portal, which you can access with a risk free trial or full annual membership.

Want to Join Us on This Journey?

Follow us as we dig deeper into this story. We’ll be sharing our findings with Premium Members, from initial research to final conclusions, and you’ll have a front-row seat if you subscribe below  to our premium service today.

OR
Receive the investing strategies that we have used for 15 years to generate superior returns, along with documented proof. Opt in for free below.
Join Email List

About GeoInvesting

Geoinvesting is a research platform founded in 2007 to publish premium research on microcap stocks that meet a certain set of criteria that we have proven leads to superior returns. Empirical evidence proves that investing in microcap stocks beats the returns of larger cap stocks by 8.24% per year. Even Warren Buffett and Peter Lynch have said that if they were to invest in one type of stock, it would be microcaps. We provide our subscribers with an even bigger edge by combining the microcap investing edge with our own tested strategies to find the best stocks that are undervalued relative to their growth prospects or other positive catalysts. Our approach is based on qualitative and quantitative factors that finds stocks a point where they are going through significant changes that the market has yet to identify. This opportunity is only available in the Microcap world, an area ignored by institutions, Wall Street and the financial media.

Over the last 15 years, we have also built a expert Microcap investor network who contribute ideas to our subscriber base.

Our History

1500+ Equities Covered
200+ Multibaggers
30+ Years Of Investing Experience
200+ Management Interview Clips

Subscribe Now For A Risk Free Trial

The post An Under-the-Radar Growth Story with Strong Fundamentals…In An Unloved Industry appeared first on GeoInvesting.


Source: https://geoinvesting.com/an-under-the-radar-growth-story-with-strong-fundamentalsin-an-unloved-industry/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.